These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6196556

  • 21. Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives.
    Jamieson M, Petrie JC, Webster J, Miller A, Harris RI, Francis RJ.
    Eur J Clin Pharmacol; 1985; 29(4):395-9. PubMed ID: 2868899
    [Abstract] [Full Text] [Related]

  • 22. Pharmacological properties of the stereoisomers of prizidilol: their use in analysis of reflex tachycardia and blood pressure control in normotensive cats, rats, and dogs.
    Owen DA, Eden RJ, Lamb MS, Taylor EM.
    J Cardiovasc Pharmacol; 1986; 8(4):743-8. PubMed ID: 2427813
    [Abstract] [Full Text] [Related]

  • 23. Dose-response curve and time course of the antihypertensive effect of SKF 92 657, a beta-receptor-blocking and vasodilating compound.
    Leonetti G, Terzoli L, Sala C, Bianchini C, Zanchetti A.
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():461s-463s. PubMed ID: 6108817
    [Abstract] [Full Text] [Related]

  • 24. Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.
    Edmondstone WM, Waller JF, Manghani KK, Hill PL, Bell AJ, Denison DM.
    Br J Clin Pharmacol; 1983 Dec; 16(6):591-8. PubMed ID: 6140939
    [Abstract] [Full Text] [Related]

  • 25. Pharmacodynamic and pharmacokinetic studies with the vasodilator endralazine.
    Elliott HL, Meredith PA, Reid JL.
    J Hypertens Suppl; 1984 Dec; 2(3):S551-4. PubMed ID: 6599716
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
    Kralberg BE, Tolagen K.
    Am J Med; 1976 May 31; 60(6):891-6. PubMed ID: 14504
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cadralazine versus prazosin as second-step treatment in hypertensive patients on beta-blockers: a randomized multicentre study. The Italian Multicentre Study Group.
    Caponnetto S, Valvo E, Mocarelli P, Alberti D, Savonitto S.
    Eur J Clin Pharmacol; 1991 May 31; 40(5):461-5. PubMed ID: 1679390
    [Abstract] [Full Text] [Related]

  • 31. [Continuous intra-arterial pressure recording for 24 hours under basal conditions and during therapy with prizidilol, a vasodilating and beta-blocking drug].
    Fariello R, Alicandri C, Boni E, Montini E, Minniti P, Cinquegrana A, Guarienti P, Zaninelli A, Agabiti-Rosei E, Muiesan G.
    Cardiologia; 1983 Feb 31; 28(2):127-31. PubMed ID: 6142722
    [No Abstract] [Full Text] [Related]

  • 32. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B, Morgan TO, Gibson J, Anderson A.
    Drugs; 1987 Feb 31; 34 Suppl 3():109-19. PubMed ID: 2894971
    [Abstract] [Full Text] [Related]

  • 33. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM.
    Clin Nephrol; 1995 Jan 31; 43(1):47-52. PubMed ID: 7697935
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R, Andrén L, Sivertsson R, Hansson L.
    Eur J Clin Pharmacol; 1984 Jan 31; 27(1):19-22. PubMed ID: 6149128
    [Abstract] [Full Text] [Related]

  • 36. Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension.
    Elliott HL, McLean K, Sumner DJ, Donnelly RJ, Reid JL.
    Clin Exp Hypertens A; 1982 Jan 31; 4(8):1409-18. PubMed ID: 6749347
    [Abstract] [Full Text] [Related]

  • 37. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH, Deering AH, Scott MG, Harron DW, Shanks RG.
    Br J Clin Pharmacol; 1987 Apr 31; 23(4):411-23. PubMed ID: 2883988
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.
    van Brummelen P, Bühler FR, Kiowski W, Bolli P, Bertel O.
    Int J Clin Pharmacol Biopharm; 1979 Oct 31; 17(10):380-5. PubMed ID: 40887
    [No Abstract] [Full Text] [Related]

  • 40. N"-Cyano-N-4-pyridyl-N'-1,2,2-trimethyl-propylguanidine, a new vasodilating agent: acute effect of blood pressure and pharmacokinetics in hypertensive patients.
    Kardel T, Hilden T, Carlsen J, Trap-Jensen J.
    J Cardiovasc Pharmacol; 1981 Oct 31; 3(5):1002-7. PubMed ID: 6168845
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.